We at the Human Microbiology Institute feel that a lack of new theoretical approaches within the scientific community has hindered the identification of novel therapeutic targets, thereby preventing the development of effective methods for treatment of diseases and increasing the human lifespan. The HMI is therefore dedicated to providing this theoretical basis for tomorrow’s medicine.
The HMI would like to present a personal and original perspective on important research-related theories to the scientific community, with the goal of stimulating debate and/or future research, and providing a new framework for, and interpretation of, existing problems.
We have developed a new theory describing the regulation of life that is analogous to the chemical periodic law in medicine. In other words, this theory enables us to reveal new connections and patterns, and thereby identify new drug targets. Identification of these targets will in turn enable the advancement of novel technologies for the development of principally new types of drugs.
Our theory has enabled us to be the first to evaluate the significance of these new therapeutic targets and to propose a fundamentally new class drugs. Furthermore, the proposed theory allow us to re-examine human longevity and the causes of many diseases that are currently considered incurable, including age-related cognitive diseases. These novel pathologies are an important basis for the creation of individualized medicine strategies.